Interactive Guidance Therapy With Video Feed-back of Parent and Child With Autism Spectrum Disorder
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Oct 23, 2020
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help young children with Autism Spectrum Disorder (ASD) and their parents through a method called Interactive Guidance Therapy with video feedback. The aim is to see how this approach can improve the interactions between parents and their children, who are between 18 months and 3 years old. To be eligible, children must have a diagnosed condition of ASD and be able to interact at a developmental level of over 12 months. It's important that one parent, who is involved in daily life with the child, participates directly in the therapy sessions.
Participants in this study can expect to take part in play sessions where they will receive guidance and feedback through video recordings. This can help them learn new ways to communicate and engage with their child. Both parents will need to provide their consent for the child to participate, and the trial is currently looking for families to join. If you think you might be eligible and are interested, it could be a great opportunity to support your child’s development in a meaningful way.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 months to 3 years child at screening
- • Child with a diagnosis of Autism Spectrum Disorder (DSM 5) or pervasive Developmental Disorder (ICD 10)
- • Child with ADI R and ADOS-2 fulfilling the criteria for TSA / PDD at diagnosis
- • Developmental age \> 12 months in motility with the Brunet-Lézine test
- • Child with availability of parent most present in daily life, only this parent participating directly in play sessions
- • Signed Informed consent form by both parents
- • Patient affiliated to the health insurance system
- Exclusion Criteria:
- • Level of language in French of parents insufficient to benefit from the care and fill in the questionnaires
- • Psychiatric parental pathology interfering with interactions with the child, qualitatively assessed by the referring psychiatrist
- • Severe sensory illness of the child (blindness, deafness, degenerative disease)
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, , France
Paris, , France
Montreuil, , France
Paris, , France
Patients applied
Trial Officials
Benoit QUIROT, MD
Study Director
EPS Ville Evrard
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials